Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Oral Etoposide in Combination With Celecoxib in Patients With Advanced Malignancies

NCT00551005 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT00551005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00551005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Oral Etoposide in Combination With Celecoxib in Patients With Advanced Malignancies
Lead sponsor
City of Hope Medical Center
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2001
Completion date
February 29, 2012
Enrollment
58 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

unspecified adult solid tumor, protocol specific